We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Vela Technologies Plc | LSE:VELA | London | Ordinary Share | GB00BYZ9XC29 | ORD 0.01P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.012 | 0.011 | 0.013 | 0.012 | 0.012 | 0.01 | 0.00 | 07:44:03 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Investment Advice | 0 | -378k | 0.0000 | N/A | 1.63M |
Date | Subject | Author | Discuss |
---|---|---|---|
18/3/2021 11:45 | Saw that, 80pence first stop.. | bullrun1 | |
18/3/2021 11:35 | MODE starting to move up from placing price. Should bring nice returns for VELA in 2021. | blueblood | |
17/3/2021 09:36 | The monetisation strategy? Upon success in 'Efficacy', the commercialisation will be expedited with the involvement of BigPharma. That should lead to a concerted rerate, above and beyond the resistance. Considering Vela has a significant holding here but also 'The' largest of all the interests, it would be unwise of JN not to have an intelligible understanding of its future value and how to best realise it... Again ,getting too entwined with pedantics buddy! | reb_ban | |
17/3/2021 07:50 | Your welcome, I suppose the results of the trial will unlock the true value of where this could go, we should then get more information from company in terms of future growth. The foundations are looking extremely strong though, exciting times ahead imo. | bullrun1 | |
16/3/2021 20:59 | Great to hear and it should provide some impetus for the share price to start gaining momentum now... | reb_ban | |
16/3/2021 20:23 | Courtesy of MrGoat LSE board Trial status completions dateToday 19:55Trial status has been updated with this. March 2021 (Final data collection date for primary outcome measure)So results in April :)https://clinicaltr | bullrun1 | |
16/3/2021 16:17 | We are investing in 'Early Stage' Disruptive Tech, traction is yet to commence with many of our interests...Consolid ...But is there any real reason for such frustration with the daily grind or just blatant impatience? | reb_ban | |
13/3/2021 13:40 | I think it would be imprudent of investors not to around present levels considering how 'Noisier' it will be getting from SGS shortly! | reb_ban | |
13/3/2021 12:46 | We bought in Wednesday and Friday. Looks primed. | oakville | |
13/3/2021 12:36 | The VC vehicle is well-diversified but some interests are still very much in 'Infancy'. However, with success in the medical trial should provide the momentum to accelerate way past the resistance... Not only do we have a 'Significant' holding here but the returns could well be substantial... | reb_ban | |
13/3/2021 09:10 | cheers, thanks for link, all looking good | currypasty | |
12/3/2021 14:03 | It is definitely in range (0.08-0.09) and unlikely it will fall outside of this unless there's some 'Serious' weakness in the global markets... | reb_ban | |
12/3/2021 08:13 | Kanabo booming again today. Value of our investment increasing rapidly! | blueblood | |
12/3/2021 01:44 | Puff, you should be used to being 'Patient' considering that you are invested with Tils...But if you have some time to inform yourself of the history to Vela and what JN has actually achieved since, it will be very informative... As you well know, its incredibly difficult to accommodate someone else's ambitions but what JN has accomplished since bringing the organisation on a more 'Balanced Footing' cannot be disputed...I'll iterate again if Arcadia trials prove successful efficacy...This will fly past the resistance, make no mistake! | reb_ban | |
11/3/2021 21:25 | It's on the -99% club for most investors, so once bitten twice shy, but every dog has its day so we may see a lucky small bounce for the patient ones. Yawn | jpuff | |
11/3/2021 20:02 | Only just back in thread good to see it's already posted | blueblood |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions